Loading...
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)
Femminella, Grazia Daniela Frangou, Eleni Love, Sharon B Busza, Gail Holmes, Clive Ritchie, Craig Lawrence, Robert McFarlane, Brady Tadros, George Ridha, Basil H
Femminella, Grazia Daniela
Frangou, Eleni
Love, Sharon B
Busza, Gail
Holmes, Clive
Ritchie, Craig
Lawrence, Robert
McFarlane, Brady
Tadros, George
Ridha, Basil H
Abstract
An amendment to this paper has been published and can be accessed via the original article.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2020-07-19
Type
Article
Subject
Files
Loading...
Correction
Adobe PDF, 194.11 KB
Citation
Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Hölscher C, Brooks DJ, Passmore AP, Ballard C, Edison P. Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). Trials. 2020 Jul 19;21(1):660. doi: 10.1186/s13063-020-04608-4. Erratum for: Trials. 2019 Apr 3;20(1):191. PMID: 32684162; PMCID: PMC7370449.